Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Opening up can unlock much-needed support, but it also comes with risks. The flare-up started like all of the others: intense ...
In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces clinical remission in primary sclerosing cholangitis-associated inflammatory ...
Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
Onlymyhealth on MSN6d
Bloating Is Common In People With Ulcerative Colitis: Expert Explains Its Causes And Management TipsBloating is a common digestive issue affecting people of all ages, however, the experience becomes more frequent and severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback